Work

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Year: 2013

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/nrclinonc.2013.177

Authors: Joaquin Mateo, Michael Ong, David S. P. Tan, Michael A. Gonzalez, Johann S. de Bono

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Research UK

OpenAlex ID: W2136652669

FWCI: 1.521

Cites: 82

Cited by: 96

Related to: 10